Why J&J offered $5.5bn to end cancer cases
Johnson & Johnson has offered $5.5 billion to settle thousands of lawsuits alleging that its talc-based products were contaminated with asbestos and caused cancer. The company maintains that its products are safe and that the claims are based on junk science, despite having already settled many mesothelioma-related cases.
Why it matters
This massive settlement highlights the ongoing legal and reputational risks corporations face regarding product safety and the long-term health impacts of consumer goods.
Allegations that some of Johnson & Johnson’s talc-based products – including their iconic baby powder – were to blame for customers developing cancer have been around for many years now.
The first cases date back to 2009, and despite multiple attempts by the company to shut the controversy down – and despite numerous adjudications and settlements – it has continued to rumble on.
Today there are still more than 70,000 cases outstanding.
The claims centre largely on allegations that the talc products caused either ovarian cancer or mesothelioma - a rare form of cancer that affects the membrane around internal organs.
That cancer has traditionally tended to afflict people who worked in mines, or in industries that used a lot of asbestos, before the risks of that material were known.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in